Sam Martin is the Senior Vice President and Chief Financial Officer at Celldex Therapeutics Inc., a biopharmaceutical company focused on developing targeted therapies for cancer and other serious diseases. In his role at Celldex, Martin oversees the company's financial strategy, planning, and operations, ensuring the organization's fiscal health and growth. His leadership has been instrumental in guiding Celldex through various stages of development, from clinical trials to potential commercialization of their innovative treatments. Before joining Celldex, Martin amassed extensive experience in the financial and healthcare sectors. He held significant positions at several prominent companies, including serving as the CFO at Tetraphase Pharmaceuticals, where he played a key role in the company's successful IPO and subsequent growth. Martin's strategic financial acumen and deep understanding of the biopharmaceutical industry have been critical in his ability to drive Celldex's financial performance and support its mission to bring life-changing therapies to patients. Martin's achievements extend beyond his corporate roles; he is also recognized for his contributions to the broader financial community. He holds a Bachelor of Science in Business Administration from the University of Vermont and an MBA from the University of Chicago Booth School of Business. His expertise and leadership have earned him respect among peers and stakeholders alike, positioning him as a pivotal figure in Celldex's ongoing success and future endeavors.